RS

Ramasamy Senthamaraikannan

Director Director DIN 03115390
DIN 03115390 First appointment Oct 2010 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Oct 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramasamy Senthamaraikannan

Data last updated:

Ramasamy Senthamaraikannan has 15 years in corporate governance. Formerly with 1 company, such as Kuber Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 03115390
Primary Designation Director
First Appointment 21 Oct 2010
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Oct 20102010–Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kuber Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramasamy Senthamaraikannan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramasamy Senthamaraikannan

Ramasamy Senthamaraikannan has 15 years in corporate governance. Formerly with 1 company, such as Kuber Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Ramasamy Senthamaraikannan has expertise in General Business.

Ramasamy Senthamaraikannan has 15 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available